Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
AngioDynamics
ANGO
$651M
| $3.33M | ﹤0.01% |
335,372
+14,463
| +5% | +$142K |
|
2502
Iovance Biotherapeutics
IOVA
$3.05B
| $3.3M | ﹤0.01% |
1,916,486
+68,745
| +4% | +$171K |
|
|
FSUN
2503
FirstSun Capital Bancorp
FSUN
$2.01B
| $3.29M | ﹤0.01% |
94,777
+31,823
| +51% | +$1.11M |
|
|
DHIL
2504
DELISTED
Diamond Hill
DHIL
| $3.28M | ﹤0.01% |
22,577
+370
| +2% | +$50.9K |
|
|
OLP
2505
One Liberty Properties
OLP
$523M
| $3.28M | ﹤0.01% |
137,463
+10,710
| +8% | +$262K |
|
2506
Cullinan Oncology
CGEM
$1.26B
| $3.28M | ﹤0.01% |
435,516
+11,254
| +3% | +$90.4K |
|
2507
Tejon Ranch
TRC
$440M
| $3.27M | ﹤0.01% |
193,001
+2,162
| +1% | +$35.6K |
|
|
KEEL
2508
Keel Infrastructure Corp
KEEL
$2.19B
| $3.26M | ﹤0.01% |
3,882,119
+73,954
| +2% | +$68.4K |
|
|
CBL
2509
CBL Properties
CBL
$1.77B
| $3.23M | ﹤0.01% |
127,371
-7,147
| -5% | -$176K |
|
2510
Aspen Aerogels
ASPN
$511M
| $3.23M | ﹤0.01% |
545,843
+58,112
| +12% | +$334K |
|
|
FFIC
2511
DELISTED
Flushing Financial
FFIC
| $3.22M | ﹤0.01% |
271,048
+5,896
| +2% | +$71.1K |
|
2512
Diageo
DEO
$52.2B
| $3.21M | ﹤0.01% |
31,855
-3,973
| -11% | -$431K |
|
|
BOW
2513
Bowhead Specialty Holdings
BOW
$1.11B
| $3.2M | ﹤0.01% |
85,219
+2,399
| +3% | +$91.9K |
|
2514
Forestar Group
FOR
$1.49B
| $3.19M | ﹤0.01% |
159,654
+3,378
| +2% | +$66.8K |
|
2515
Regenxbio
RGNX
$721M
| $3.18M | ﹤0.01% |
387,503
+20,954
| +6% | +$175K |
|
|
MRX
2516
Marex Group Limited Ordinary Shares
MRX
$5.12B
| $3.17M | ﹤0.01% |
+80,223
| New | +$3.34M |
|
2517
Eve Holding
EVEX
$944M
| $3.16M | ﹤0.01% |
460,992
+29,365
| +7% | +$131K |
|
2518
Orthofix Medical
OFIX
$424M
| $3.13M | ﹤0.01% |
281,085
-43,762
| -13% | -$542K |
|
2519
CryoPort
CYRX
$749M
| $3.13M | ﹤0.01% |
419,813
+49,511
| +13% | +$307K |
|
2520
Celcuity
CELC
$4.49B
| $3.11M | ﹤0.01% |
233,059
+1,023
| +0.4% | +$11.1K |
|
|
BKV
2521
BKV Corp
BKV
$2.86B
| $3.1M | ﹤0.01% |
128,433
+8,002
| +7% | +$165K |
|
2522
Kearny Financial
KRNY
$601M
| $3.1M | ﹤0.01% |
479,494
+11,604
| +2% | +$71.5K |
|
2523
Cytek Biosciences
CTKB
$623M
| $3.09M | ﹤0.01% |
909,590
-195,299
| -18% | -$651K |
|
|
FFWM
2524
DELISTED
First Foundation Inc
FFWM
| $3.08M | ﹤0.01% |
604,154
+51,091
| +9% | +$262K |
|
2525
Tango Therapeutics
TNGX
$4.31B
| $3.08M | ﹤0.01% |
601,447
+53,433
| +10% | +$132K |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.